These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1588118)

  • 1. Toxicity and side-effects of combination chemohormonal therapy of advanced breast cancer.
    Mohapatro SK; Dandapat MC; Padhi NC
    J Indian Med Assoc; 1992 Feb; 90(2):39-42. PubMed ID: 1588118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
    Goldhirsch A; Gelber R
    NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer.
    Tormey DC; Gray R; Taylor SG; Knuiman M; Olson JE; Cummings FJ
    NCI Monogr; 1986; (1):75-80. PubMed ID: 3534593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Side effects of adjuvant therapies of breast cancer: their significance for the patient].
    Langer M; Flores-Genger H; Sevelda P; Fiegl J; Ringler M; Kubista E
    Wien Klin Wochenschr; 1989 Feb; 101(4):134-8. PubMed ID: 2929157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in locally advanced breast cancer.
    Singh G; Singh DP; Gupta D; Muralikrishna BV
    J Surg Oncol; 1996 Jan; 61(1):38-41. PubMed ID: 8544458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
    Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
    J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer.
    Martoni A; Rani P; Ercolino L; Canova N; Pannuti F
    Chemioterapia; 1988 Oct; 7(5):345-9. PubMed ID: 3224403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced nausea, vomiting, and fatigue--the role of individual differences related to sensory perception and autonomic reactivity.
    Zachariae R; Paulsen K; Mehlsen M; Jensen AB; Johansson A; von der Maase H
    Psychother Psychosom; 2007; 76(6):376-84. PubMed ID: 17917474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer.
    Danforth DN; Lippman ME; McDonald H; Bader J; Egan E; Lampert M; Steinberg SM; Swain SM
    Am Surg; 1990 Jan; 56(1):6-11. PubMed ID: 2153011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant combined radiochemotherapy: a feasibility study of a new strategy in stages I and II].
    Serin D; Aimard L; Kirscher S; Brewer Y; Félix-Faure C; Vincent P; Chauvet B; Reboul F
    Bull Cancer; 1997 Mar; 84(3):247-53. PubMed ID: 9207869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
    Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
    Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
    Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
    Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma.
    Wilcox PM; Fetting JH; Nettesheim KM; Abeloff MD
    Cancer Treat Rep; 1982 Aug; 66(8):1601-4. PubMed ID: 7049385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery.
    Lippman ME; Sorace RA; Bagley CS; Danforth DW; Lichter A; Wesley MN
    NCI Monogr; 1986; (1):153-9. PubMed ID: 3022156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.
    Swain SM; Sorace RA; Bagley CS; Danforth DN; Bader J; Wesley MN; Steinberg SM; Lippman ME
    Cancer Res; 1987 Jul; 47(14):3889-94. PubMed ID: 3036348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive combined modality therapy for advanced local-regional breast carcinoma.
    Loprinzi CL; Carbone PP; Tormey DC; Rosenbaum PR; Caldwell W; Kline JC; Steeves RA; Ramirez G
    J Clin Oncol; 1984 Mar; 2(3):157-63. PubMed ID: 6230422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.